U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C8H20N2.2ClH
Molecular Weight 217.18
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Octamoxin dihydrochloride

SMILES

Cl.Cl.CCCCCCC(C)NN

InChI

InChIKey=IIMQLRCJHVVMMR-UHFFFAOYSA-N
InChI=1S/C8H20N2.2ClH/c1-3-4-5-6-7-8(2)10-9;;/h8,10H,3-7,9H2,1-2H3;2*1H

HIDE SMILES / InChI

Description

Octamoxine (ximaol), a monoamine oxidase inhibitor was used as an antidepressant to treat mental depression. Now this drug is no longer marketed.

Approval Year

Unknown
149124
PubMed

PubMed

TitleDatePubMed
[Indications and results of the treatment of mental depression by octamoxine (ximaol)].
1966-09-01
[Relations between the antidepressive effects of octamoxine revealed by 3 pharmacological tests and inhibition of cerebral monoamine oxidase in mice].
1966-07-01
Name Type Language
Hydrazine, (1-methylheptyl)-, hydrochloride (1:2)
Preferred Name English
Octamoxin dihydrochloride
Common Name English
Octan-2-ylhydrazine dihydrochloride
Systematic Name English
Code System Code Type Description
CAS
1375473-75-8
Created by admin on Tue Apr 01 16:21:05 GMT 2025 , Edited by admin on Tue Apr 01 16:21:05 GMT 2025
PRIMARY
FDA UNII
7M2K9S9EWZ
Created by admin on Tue Apr 01 16:21:05 GMT 2025 , Edited by admin on Tue Apr 01 16:21:05 GMT 2025
PRIMARY
PUBCHEM
73994667
Created by admin on Tue Apr 01 16:21:05 GMT 2025 , Edited by admin on Tue Apr 01 16:21:05 GMT 2025
PRIMARY
PARENT (SALT/SOLVATE)
Structure of OCTAMOXIN
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966